Aclasta infusion is a treatment used for certain bone and mineral conditions, including osteoporosis, where clinically appropriate. The treatment involves administering Aclasta (zoledronic acid) through an intravenous infusion under medical supervision. Patients are assessed beforehand to determine suitability, with appropriate monitoring and follow-up provided as part of the treatment process.
Most babies can feed normally immediately after a tongue tie release. Mild fussiness or discomfort during the first few feeds
Gentle assessment and tongue tie release for babies experiencing feeding difficulties.
Assessment and treatment for tongue tie (ankyloglossia), including tongue tie release for babies and children when clinically appropriate.
A quick and gentle injection that helps protect newborns from Vitamin K Deficiency Bleeding (VKDB).
Assessment and treatment for tongue tie in babies and children, including tongue tie release where clinically appropriate.
Telehealth consultations provide convenient access to medical care by phone or video, where clinically appropriate.